合成致死
聚ADP核糖聚合酶
同源重组
杀伤力
DNA修复
聚合酶
生殖系
生物
癌症研究
突变
PARP抑制剂
DNA损伤
基因
癌症
遗传学
DNA
作者
Susanne Burdak‐Rothkamm,Kai Rothkamm
标识
DOI:10.1016/j.molmed.2020.09.011
摘要
Synthetic lethality describes a concomitant inactivation of two genes leading to cell death, whereas single loss of either gene is not lethal. Poly ADP ribose polymerase (PARP) inhibitors are the prototype of a synthetic lethality-based treatment for cancers with homologous recombination repair (HRR) deficiency, for example, breast cancers with germline BRCA1/2 gene mutation.
科研通智能强力驱动
Strongly Powered by AbleSci AI